Alliance Wealth Advisors (Utah)’s Prestige Consumer Healthcare PBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-8,728
Closed -$517K 247
2026
Q1
$517K Sell
8,728
-355
-4% -$23K 0.11% 131
2025
Q4
$560K Sell
9,083
-3,432
-27% -$210K 0.12% 160
2025
Q3
$781K Buy
12,515
+538
+4% +$37.5K 0.18% 138
2025
Q2
$956K Buy
11,977
+194
+2% +$16.2K 0.23% 101
2025
Q1
$1.01M Buy
11,783
+254
+2% +$20.8K 0.26% 94
2024
Q4
$900K Buy
11,529
+672
+6% +$52.2K 0.23% 108
2024
Q3
$783K Buy
10,857
+945
+10% +$66.9K 0.21% 116
2024
Q2
$682K Buy
9,912
+899
+10% +$60.9K 0.2% 116
2024
Q1
$654K Buy
9,013
+1,022
+13% +$68.3K 0.2% 115
2023
Q4
$489K Buy
7,991
+458
+6% +$27.2K 0.16% 131
2023
Q3
$431K Buy
7,533
+516
+7% +$31.2K 0.16% 137
2023
Q2
$417K Buy
7,017
+909
+15% +$54.4K 0.15% 141
2023
Q1
$383K Buy
6,108
+527
+9% +$32.9K 0.15% 142
2022
Q4
$349K Buy
+5,581
New +$320K 0.16% 144

Other funds holding PBH

Alliance Wealth Advisors (Utah)'s PBH Position: Q2 2026 in Review

Alliance Wealth Advisors (Utah) sold out of Prestige Consumer Healthcare (PBH) in Q2 2026, closing a stake of 8,728 shares — an estimated $517K sold.

Alliance Wealth Advisors (Utah) first reported a position in PBH in Q4 2022 and held it in 14 quarters. The position peaked at $1.01M in Q1 2025. 318 funds tracked by Wall St. Rank hold PBH as of Q2 2026.

  • Alliance Wealth Advisors (Utah) reported no remaining Prestige Consumer Healthcare position as of Q2 2026 after selling out during the quarter.
  • Alliance Wealth Advisors (Utah) sold 8,728 Prestige Consumer Healthcare shares in Q2 2026, an estimated $517K.
  • Alliance Wealth Advisors (Utah) first reported a position in Prestige Consumer Healthcare in Q4 2022 and held it in 14 quarters.
  • Alliance Wealth Advisors (Utah)'s Prestige Consumer Healthcare position peaked at $1.01M in Q1 2025.
  • 318 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q2 2026.

Based on Alliance Wealth Advisors (Utah)'s 13F filing for Q2 2026, filed 23 Jul 2026.